Annovis Bio Inc (ANVS)

May 15, 2026

Annovis Bio, Inc. Common Stock (NY: ANVS - The Chronicle-Journal

May 15, 2026

May 15, 2026

Annovis Bio, Inc. 1Q 2026: Net income $(17.61M), EPS $(0.63) — 10-Q Summary - TradingView

May 15, 2026

May 15, 2026

Rising R&D and going-concern risk at Annovis Bio (ANVS) as cash falls - Stock Titan

May 15, 2026

May 15, 2026

Annovis Bio (NYSE: ANVS) ramps R&D as Phase 3 Alzheimer’s trial advances - Stock Titan

May 15, 2026

May 15, 2026

Annovis Bio Releases Q1 2026 Financial Results - AlphaStreet

May 15, 2026

May 15, 2026

Annovis Bio Inc reports results for the quarter ended December 31Earnings Summary - TradingView

May 15, 2026

May 15, 2026

Annovis Provides Corporate Updates and Reports First Quarter 2026 Financial Results - The Manila Times

May 15, 2026

May 14, 2026

ANVS Stock Price, Quote & Chart | ANNOVIS BIO (NYSE:ANVS) - ChartMill

May 14, 2026

May 13, 2026

TradingKey - TradingKey

May 13, 2026

May 13, 2026

Malvern company closes $10M offering to extend Alzheimer’s therapy testing - Pennsylvania Business Report -

May 13, 2026

May 11, 2026

ANVS Technical Analysis | Trend, Signals & Chart Patterns | ANNOVIS BIO (NYSE:ANVS) - ChartMill

May 11, 2026

May 08, 2026

ANVS Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

May 08, 2026

May 07, 2026

Annovis Bio CEO to Present Multi-Protein Approach to Alzheimer’s at Fierce Biotech Week - MEXC

May 07, 2026

May 07, 2026

Annovis CEO to Present on Multi-Protein Model of Alzheimer's Disease at Fierce Biotech Week 2026 - mydailyrecord.com

May 07, 2026

May 07, 2026

Annovis CEO to Present on Multi-Protein Model of Alzheimer's Disease at Fierce Biotech ... - Herald and News

May 07, 2026

May 06, 2026

Number of shareholders of Annovis Bio Inc – FWB:07X - TradingView

May 06, 2026

May 05, 2026

Annovis Bio Publishes Phase 2/3 Alzheimer’s Trial Results - MyChesCo

May 05, 2026

May 01, 2026

Annovis Bio Appoints Accomplished Neuroscientist, Dr. Cheng Fang as VP of Research - TMX Newsfile

May 01, 2026

May 01, 2026

ANVS Earnings History & Surprises | EPS & Revenue Results | ANNOVIS BIO (NYSE:ANVS) - ChartMill

May 01, 2026

Apr 30, 2026

Annovis Bio | DEF 14A: Definitive information statements - Moomoo

Apr 30, 2026

Apr 30, 2026

Annovis Bio (ANVS) seeks approval to expand 2019 equity incentive plan at 2026 meeting - Stock Titan

Apr 30, 2026

Apr 29, 2026

Annovis Bio (ANVS) price target increased by 13.94% to 15.98 - MSN

Apr 29, 2026

Apr 28, 2026

Annovis Bio reports positive cognition data in early Alzheimer’s trial - Investing.com UK

Apr 28, 2026

Apr 28, 2026

Annovis Bio reports positive cognition results in early Alzheimer’s trial By Investing.com - Investing.com Australia

Apr 28, 2026

Apr 28, 2026

Annovis Bio reports positive cognition data in early Alzheimer’s trial By Investing.com - Investing.com Australia

Apr 28, 2026

Apr 28, 2026

Annovis Publishes Phase 2/3 Alzheimer's Trial Results in Nature Portfolio - The Manila Times

Apr 28, 2026

Apr 28, 2026

Annovis Bio reports positive cognition results in early Alzheimer’s trial - Investing.com

Apr 28, 2026

Apr 28, 2026

Annovis Bio, Inc. (NYSE:ANVS) Sees Significant Increase in Short Interest - MarketBeat

Apr 28, 2026

Apr 28, 2026

Annovis Bio Announces Transfer of Listing to the New York Stock Exchange - TMX Newsfile

Apr 28, 2026

Apr 28, 2026

Annovis Bio Announces Positive FDA Feedback for Buntanetap Phase 3 Clinical Development in Parkinson's Disease - TMX Newsfile

Apr 28, 2026

Apr 28, 2026

Annovis Bio Presents at International Conference on Alzheimer's & Parkinson (AD/PD 2022) - TMX Newsfile

Apr 28, 2026

Apr 28, 2026

Annovis Bio to Participate in the Biotech Showcase and H.C. Wainwright Bioconnect Virtual Conferences - TMX Newsfile

Apr 28, 2026

Apr 28, 2026

Annovis Bio Announces Publication of ANVS401 Mechanism of Action in Peer-Reviewed Pharmaceutics - TMX Newsfile

Apr 28, 2026

Apr 28, 2026

Annovis Bio Presented At The 14th Clinical Trials on Alzheimer's Disease Conference - TMX Newsfile

Apr 28, 2026

Apr 28, 2026

Annovis Bio Announces Presentation at International Conference on Alzheimer's & Parkinson's Diseases 2022 - TMX Newsfile

Apr 28, 2026

Apr 24, 2026

Annovis Bio Announces Cooperative Research and Development Agreement (CRADA) with the National Institute on Aging - TMX Newsfile

Apr 24, 2026

Apr 24, 2026

Annovis Bio Presents Poster on Mechanism of Action at the 14th Clinical Trials on Alzheimer's Disease (CTAD) Conference - TMX Newsfile

Apr 24, 2026

Apr 23, 2026

Traders Buy Large Volume of Annovis Bio Call Options (NYSE:ANVS) - MarketBeat

Apr 23, 2026

Apr 14, 2026

Annovis Bio Price Target Maintained With a $17.00/Share by Canaccord Genuity - Moomoo

Apr 14, 2026

Apr 13, 2026

Aug Summary: Will Annovis Bio Inc stock recover after earnings2026 Chart Watch & Technical Pattern Recognition Alerts - baoquankhu1.vn

Apr 13, 2026

Apr 13, 2026

Fed Watch: Can Annovis Bio Inc disrupt its industry2026 Spike Watch & Safe Capital Preservation Plans - baoquankhu1.vn

Apr 13, 2026

Apr 13, 2026

Retail Trends: Will Annovis Bio Inc benefit from seasonalityPortfolio Growth Summary & Free Real-Time Volume Trigger Notifications - baoquankhu1.vn

Apr 13, 2026

Apr 10, 2026

Annovis Bio raises $10M to fund Alzheimer’s drug trial By Investing.com - Investing.com Australia

Apr 10, 2026

Apr 10, 2026

Annovis Bio highlights buntanetap development in published article - MSN

Apr 10, 2026

Apr 10, 2026

Annovis secures financing for buntanetap’s NDA submission - The Pharma Letter

Apr 10, 2026

Apr 10, 2026

Annovis Bio raises $10M to fund Alzheimer’s drug trial - Investing.com

Apr 10, 2026

Apr 10, 2026

A $10M cash boost puts Annovis on track for an Alzheimer’s drug filing - Stock Titan

Apr 10, 2026